Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference
Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here.
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...
'It changed my life tremendously': P.E.I.'s new ketamine clinic could offer mental health help
Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...
Hosted on MSN6d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to know
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
Understanding the Causes and Symptoms of Allergic Rhinitis
VMPL New Delhi [India] January 31 Allergic rhinitis is a very common condition often termed as hay fever which affects millions of people globally This chronic condition arises from the reaction of th ...